About

About ImmunoShield Therapeutics ImmunoShield Therapeutics is a regenerative medicine/biotechnology startup whose goal is to bring safer cell therapies to patients. Regenerative medicine therapeutics and allogeneic cell-based therapies meant to treat a variety of disorders are racing through clinical trials, but they lack high throughput means to generate cell-laden hydrogel devices and their implementation is limited to patients with disease severe enough to justify the risk of immunosuppressive therapy. Methods to generate cell-laden hydrogel constructs in the clinic or biomanufacturing, as well as means to eliminate chronic systemic immunosuppression would vastly broaden the available patient market for both of these broad application spaces. ImmunoShield Therapeutics aims to address these challenges through the Hydrogel Injection Molding method. About ImmunoShield Therapeutics ImmunoShield Therapeutics is a regenerative medicine/biotechnology startup whose goal is to bring safer cell therapies to patients. Regenerative medicine therapeutics and allogeneic cell-based therapies meant to treat a variety of disorders are racing through clinical trials, but they lack high throughput means to generate cell-laden hydrogel devices and their implementation is limited to patients with disease severe enough to justify the risk of immunosuppressive therapy. Methods to generate cell-laden hydrogel constructs in the clinic or biomanufacturing, as well as means to eliminate chronic systemic immunosuppression would vastly broaden the available patient market for both of these broad application spaces. ImmunoShield Therapeutics aims to address these challenges through the Hydrogel Injection Molding method. ImmunoShield Therapeutics is empowering cell therapies by pioneering scalable biomanufacturing and immune tolerance technologies. Our mission is to transform outcomes for patients with chronic diseases, such as type 1 diabetes, by dramatically improving the safety, efficacy, and accessibility of next-generation cell therapies designed to provide functional cures. Recognizing that manufacturing bottlenecks often limit patient access, we are enabling high-throughput, automated production of encapsulated cell therapies, ensuring more patients can benefit from safe, effective treatments and regain control of their health.